Advanced Bionics
Laubisrütistrasse 28, Stäfa, ZH, 8712, Switzerland
Overview
Advanced Bionics Corporation develops implantable neurostimulation devices. The company develops and manufactures cochlear implants. Its devices restore hearing in the deaf and alleviate chronic pain. Advanced Bionics Corporation was founded in 1993 and is headquartered in Valencia, California with additional offices in Rixheim, France; Valencia, California; and Tokyo, Japan.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 3
Sector focus
- Developer Platform
- Manufacturing
- Medical Device
Investment portfolio
- Spiral Therapeutics
Participated · Series B · Apr 2026
Spiral Therapeutics is a clinical-stage biotech company focused on developing therapies for inner ear disorders, including hearing loss and balance disorders, and advancing its MICS™ (Minimally-Invasive Cochlear System) drug delivery platform. The company’s lead program, SPT-2101, produced a statistically significant reduction in overall vertigo in patients with Ménière’s disease, and Spiral is preparing for a registrational clinical trial. Spiral’s pipeline also includes neurotrophic approaches and other hearing loss programs enabled by precision cochlear delivery. Recent financing will fund continued development of SPT-2101 and expansion of the MICS™ platform. Spiral announced an R&D collaboration with Advanced Bionics to evaluate sustained local drug delivery at the time of cochlear implantation. The company is based in South San Francisco.